Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Pathophysiology of polymyalgia rheumatica (PMR) is ill defined. This study aims at
characterizing immunological abnormalities in PMR patients, and to assess the effects of
tocilizumab therapy on this abnormalities.